RetaMaps

Nirvana Aesthetics and Wellness

Nirvana Aesthetics and Wellness · 1372 Wellbrook Circle · Conyers, GA 30012

5.0· 48 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Nirvana Aesthetics and Wellness is an aesthetics practice in Conyers, Georgia, whose website describes skincare, laser and body treatments, sexual wellness services and weekly weight-loss injections; the listing also includes hormone care and IV therapy. The site introduces Malaka Sams, dual licensed as an aesthetician and cosmetic laser practitioner. Because the injections are offered at an aesthetics practice, anyone interested should ask who prescribes them and how visits are supervised. Google shows a 5.0-star rating across 48 reviews dating back to 2024, 1 in the past year; reviewers mention the providers' knowledge, results and scheduling.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 48 reviews
1
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2025-12-02. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 48 Google reviews. Of the 15 reviews we analyzed, 15 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers5 reviews
  • Weight-loss results3 reviews
  • Easy scheduling and communication3 reviews
  • Friendly, helpful staff2 reviews

Common complaints

No negative reviews among those we analyzed.

5★
14
4★
1
3★
0
2★
0
1★
0

Most recent Google reviews

Princess S.★★★★★2025-12-02

Bryanna is a treasure! Very helpful, will inform you of upkeep, and is extremely knowledgable of her craft. If youre ever in town, come see her :)

Fred S.★★★★★2025-09-04

I recently have had a few micro needling appointments with Bryanna Allen. I HIGHLY recommend her!!! She was very patient and kind throughout the process.

Mandeep K.★★★★★2025-09-04

Bryanna Allen gave me laser treatment. I am fully satisfied. She is very knowledgeable. I got my second treatment from her. She is doing great. Thank you dear

Victoria S.★★★★★2025-08-28

Absolutely fantastic experience. I love the results and Bryanna is a great help!! Thank you for my new life.

Lydia R.★★★★★2025-08-26

“ I highly recommend this wellness center. I’ve been to other places but this place really impressed me with their professionalism and customer service. Staff is very friendly especially Ms Bryanna.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Conyers

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs